1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Sepsis - Epidemiology Forecast to 2023

  • March 2015
  • 65 pages
  • GlobalData
Report ID: 2838399

Summary

Table of Contents

Search Inside

EpiCast Report: Sepsis - Epidemiology Forecast to 2023

Summary

Sepsis is a life-threatening complication arising from an infection; it occurs when the body’s response to the infection damages its own tissues and organs. Anyone can develop sepsis; however, the condition is more common among children <1 year of age, older adults, and those with weakened immune systems (Mayo Clinic, 2014). Global estimates for the year 2013 showed that there are around 20 to 30 million patients affected by sepsis every year, of which around 8 million patients die (Reinhart et al., 2013).

In the 6MM, the diagnosed incident cases of sepsis will grow from 1,060,052 cases in 2013 to 1,129,816 cases in 2023, at an Annual Growth Rate (AGR) of 0.66% over the forecast period. Throughout the forecast period, the US will have the highest number of diagnosed incident cases of sepsis in the 6MM. the sepsis mortality cases will increase from 439,015 cases in 2013 to 531,282 cases in 2023, at an AGR of 2.10% from 2013 to 2023 in the 6MM. GlobalData epidemiologists attribute the growth in the diagnosed incident cases of sepsis and sepsis mortality cases in the 6MM to changing population demographics in the respective markets.

GlobalData’s epidemiological analysis is supported by the use of country-specific diagnosed incidence and mortality data from epidemiological studies published in peer-reviewed journals. GlobalData epidemiologists used uniform methodology across the 6MM to forecast the diagnosed incident cases of sepsis and sepsis mortality cases to allow for a meaningful comparison of the disease populations across markets.

Scope

- The Sepsis EpiCast Report provides an overview of the risk factors and global trends of sepsis in the 6MM (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiology forecast for the diagnosed incident cases of sepsis segmented by sex, age, severity stage, and causative organism; a 10-year epidemiology forecast for the sepsis mortality cases segmented by sex, age, severity stage, and causative organism. Additionally, the report provides a 10-year epidemiological forecast for the diagnosed incident cases of sepsis that have comorbid conditions disseminated intravascular coagulopathy (DIC), acute respiratory distress syndrome (ARDS), acute lung injury (ALI), and acute kidney injury (AKI) in the 6MM.
- The sepsis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global sepsis market.
- Quantify patient populations in the global sepsis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis therapeutics in each of the markets covered.
- Identify the percentage of sepsis incident and mortality cases by severity stage and causative organism.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: Sickle Cell Disease Forecast in 10 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • July 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Sickle Cell Disease in 10 Major Markets Sickle cell disease (SCD) is a term comprising clinically relevant haemoglobinopathies caused ...

Global Genetic Testing Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global genetic testing market accounted for USD 3.8 Billion in 2015 and is estimated to reach USD 4.23 billion in 2016. Growing at a moderately high CAGR of 9.7%, the market value is expected to reach ...

Blood Disease Drugs Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.